Medical Disorders
Resources
Basic InformationLookupsLatest News
New Hope Against Diseases Marked by Progressive Scarring of Lung TissueAHA News: What Heart and Stroke Patients Should Know About COVID-19 VaccinesCOVID Pandemic Shortened U.S. Life Expectancy by More Than a YearShorter COVID Quarantine for College Athletes a Good Idea, Study FindsWhat Happened to the Flu This Year?3 Steps Could Nearly Eliminate COVID Infections on College Campuses: StudyPharmacy Chains Ready to Supply COVID-19 Vaccines to AmericansI've Already Had COVID-19, Do I Need the Vaccine?What Will COVID-19 Look Like Years From Now?First Computer Model of Entire COVID Virus Will Aid ResearchStopping Common Heart Meds Could Be Risky for Kidney PatientsU.S. COVID Vaccine Rollout Nears 1 Million Doses Per DayJohnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialLockdowns' Benefits for Air Quality Weren't as Big as Thought: StudyPeople's 'Microbiomes' Might Influence COVID-19 Severity: StudyNew Insights Into How COVID-19 Damages the BrainCollege Campuses Are COVID 'Superspreaders,' Study FindsStuck at Home, Suffering With COVID? Experts Offer Guidance on CareCOVID Daily Death Toll Sets New U.S. Record, Soars Past 4,400AHA News: Registries Could Offer Insight Into COVID-19's Impact on College Athletes' HeartsResearch Reveals Why COVID Pneumonia Is More DeadlyPandemic Is Tied to Big Rise in U.S. Heart DeathsCommon Diabetes Meds Tied to Serious COVID-19 ComplicationPlant-Based Diet Brings Better 'Microbiome,' Healthier LifeAnswering Your Qs on the New COVID VaccinesCommon Blood Pressure Meds Won't Up Risks for COVID Patients: StudyHealth Officials Work to Speed Up U.S. COVID Vaccine RolloutAllergists' Group Offers Guidelines on COVID-19 VaccinesFacebook Posts Big Drivers in Vaccine Resistance, Study FindsBlack Patients at Higher Risk When Type 1 Diabetes and COVID CombineBiden Says He Will Release All Vaccine Doses After Taking Office'Pandemic Fatigue' Setting in? Here's How to Stay Safe and StrongCould High Pollen Levels Trigger Pelvic Pain?Record Number of COVID Cases, Deaths Reported in U.S.COVID Survivors' Plasma Might Prevent Worsening Illness in Older Patients: StudyAHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Certain Antibiotics Linked With Upped Risk for Deadly Aortic AneurysmsDeath Risk Nearly Doubles When COVID Strikes People With Heart FailureMore Infectious COVID Variant Likely Widespread in the U.S., Experts SayRed Cross Issues Call for More Blood Plasma to Treat COVID PatientsPediatricians' Group Says School Is Priority, With Proper Safety MeasuresMoves, Evictions Often Trigger Harmful Breaks in Health Care: StudyAllergic Reactions to COVID Vaccines Are Rare, Resolved on Site: CDCSurvey Shows Mental Woes Spiked in U.S. Pandemic's First MonthsYour 'To-Do' List as You Await a COVID VaccineSome Americans Can't Access Telemedicine, Study ShowsU.S. COVID Hospitalizations Reach Record High as California Hospitals Run Out of OxygenVaccine Rollout Could Have Americans Back to Normalcy by Summer, Expert SaysCould Umbilical Cord Stem Cells Be a Lifesaver Against Severe COVID-19?Kids With Congenital Heart Disease Face Higher Odds of Mental Health Issues
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

COVID-19 Immunity Might Last at Least 8 Months: Study

HealthDay News
by By Dennis Thompson HealthDay Reporter
Updated: Dec 31st 2020

new article illustration

THURSDAY, Dec. 31, 2020 -- Folks who contract COVID-19 can expect to gain some durable immunity against future infection, according to a new study of memory cells within the immune systems of coronavirus patients.

Previous studies have raised concern that COVID-19 patients might lose their immunity quickly once they recover, because the first wave of coronavirus antibodies tends to wane after the first few months.

But painstaking work by Australian researchers has revealed that people infected with the SARS-CoV-2 virus have immune memory to protect against reinfection for at least eight months.

Samples from 25 COVID-19 patients found that they continued to carry stable levels of virus-specific memory B cells as long as eight months after their infection, the researchers reported online recently in the journal Science Immunology.

"Because of the biology of the persistence of these memory cells, it anticipates that we will have rather durable immunity," said Dr. William Schaffner, a professor of infectious diseases at Vanderbilt Medical Center in Nashville, Tenn.

"It can't tell us for exactly how long, but it does conform with the observation that documented second infections have been, to this point, really quite rare," said Schaffner, who was not involved with the new study.

This discovery indicates that COVID-19 vaccines will create lasting immunity, said senior researcher Menno van Zelm. He's an associate professor at the Monash University department of immunology and pathology, in Melbourne.

"This has been a black cloud hanging over the potential protection that could be provided by any COVID-19 vaccine and gives real hope that, once a vaccine or vaccines are developed, they will provide long-term protection," van Zelm said in a journal news release.

After the body successfully fends off an infection, some of the immune cells that were part of the defense are converted into "memory" cells that remember the virus or bacteria they just fought.

These cells live in the body for a long time, and provide a blueprint for the immune system to fight off any future infections from the same pathogens.

For the new study, the researchers analyzed 36 blood samples taken from 25 COVID-19 patients, and found that antibody levels did indeed show a marked decline around 20 days after the onset of symptoms.

But memory B cell levels continued to rise as far out as 150 days, the investigators found, suggesting that the body remained ready and able to quickly churn out virus-specific antibodies when faced with a future infection.

Memory B cells specific to COVID-19 were found in samples taken 242 days after symptom onset, the results showed.

According to Schaffner, "It does really suggest that once we experience the infection, our immune response recognizes the foreignness of COVID and sets up a mechanism so it will be able to respond very quickly down the road should we be exposed to the virus a second time."

Because COVID-19 has only been around for about a year, experts still can't say exactly how long that immune protection will last, noted Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, in Baltimore.

The possibility remains that people might need regular COVID-19 vaccine shots, just as there are annual flu shots.

"It appears, like with many infectious diseases, recovery from COVID-19 is associated with a period of immunity that extends at least several months," Adalja said. "It will be important to determine how long immunity -- natural and vaccine-induced -- lasts in order to optimize vaccine schedules; it will likely be a year or more."

In the meantime, these results indicate that COVID-19 survivors who fall ill a second time probably have picked up some other bug, he noted.

"For those who have recently recovered, it's important to think of other causes for symptoms, as reinfection is very rare in the months post-infection," Adalja said.

While these memory B cells provide welcome news of lasting protection, they circulate in such low levels in the body that it's unlikely they could form the basis of another new type of COVID-19 test, Schaffner said.

"The cells that are circulating are there in very small numbers. So you have to pick them out, and you have to pick them out against a lot of background noise," Schaffner said. "Part of the reason this got into this prestigious journal is that these investigators really went to great lengths to quite definitively find these small circulating memory B cells."

More information

Arizona State University has more about immune memory cells.

SOURCES: William Schaffner, MD, professor of infectious disease, Vanderbilt Medical Center, Nashville, Tenn.; Amesh Adalja, MD, senior scholar, Johns Hopkins Center for Health Security, Baltimore; Science Immunology, Dec. 22, 2020, online




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net